Font Size: a A A
Keyword [checkpoint inhibitor]
Result: 1 - 20 | Page: 1 of 2
1. Research On Cell Cycle G2/M Checkpoint Inhibitors Synthesis And Activity
2. Synergistic Effects Of The Immune Checkpoint Inhibitor CTLA-4 Combined With The Growth Inhibitor Lycorine In A Mouse Model Of Renal Cell Carcinoma
3. Clinically Experimental Investigation Of Biomarkers Of Peripheral Blood As Potential Predictors Of The Efficacy Of Immune Checkpoint Blockade In Patients With Solid Tumors
4. Clinical Relevance And Mechanistic Study Of TCR Repertoire Usage As A Biomarker For Immunotherapy In NSCLC Patients
5. Synergistic Effect Of Radiofrequency Ablation And Immune Checkpoint Inhibitors On Advanced Kidney Cancer And Its Imaging Evaluation
6. Exosomal PD-L1 And Immune Model Influence The Prognosis Of Advanced Tumor And Immunotherapy Response And The Mechanism
7. The Research Progress On PD-1/PD-L1 Immune Checkpoint Inhibitor Treating Advanced Bladder Cancer
8. Post-marketing Study Of Safety Of Immune Checkpoint Inhibitor Based On Spontaneous Reporting System
9. Distant Metastasis Patterns And Abscopal Effects Of Non-small Cell Lung Cancer
10. Adverse Events Associated With Immune Checkpoint Inhibitors For Solid Tumor:A Systematic Review And Meta-analysis
11. The Efficacy And Safety Of Combined Immune Checkpoint Inhibitors In The First-line Treatment Of Advanced Lung Cancer:a Network Meta-analysis
12. Pembrolizumab-an Anti-PD-1 Agent In Treatment Of Tripe Negative Breast Cancer: Recent Findings And Next Move
13. Clinical Observation Of Immune Checkpoint Inhibitor In The Treatment Of Advanced Non-Small Cell Lung Cancer
14. Elevated Levels Of IL-17A And IL-35 In Plasma And Bronchoalveolar Lavage Fluid(BALF) Are Associated With Checkpoint Inhibitor Pneumonitis(CIP) In Patients With NSCLC
15. Study On Effect And Mechanism Of High-dose Vitamin C Combined With Immune Checkpoint Inhibitor In Treating Liver Cancer
16. Medical Imaging And Texture Analysis In Response Evaluation And Prognosis Prediction For Metastatic Renal Clear Cell Carcinoma Patients Treated With PD-1 Inhibitor Therapy
17. The Predictive Value And Underlying Mechanisms Of M1 Macrophage For Anti-PD-L1 Therapy Efficacy In Urothelial Cancer
18. Biomarkers Associated With Response And Immune-related Adverse Events For Immune Checkpoint Inhibitors
19. NLRP4-mediated Response Immune Checkpoint Inhibitor Therapy Benefits In Tumor Microenvironment
20. Application Of Radiomics In Predicting The Efficacy Of Immunotherapy For Solid Tumors
  <<First  <Prev  Next>  Last>>  Jump to